๐ŸŽ Black Friday: 50% off Unlimited and 30% off Pro annual plans
GoodRx Holdings, Inc. (GDRX)
NASDAQ: GDRX ยท Real-Time Price ยท USD
2.920
-0.100 (-3.31%)
At close: Nov 20, 2026, 4:00 PM EST
2.880
-0.040 (-1.37%)
After-hours: Nov 20, 2026, 7:50 PM EST

GoodRx Holdings Earnings Call Transcripts

Fiscal Year 2026

  • Q2 2026 results exceeded expectations with strong growth in Pharma Direct (up 76% YoY) and subscriptions (up 39% YoY), prompting raised full-year revenue and EBITDA guidance. Strategic focus on scaling new offerings and deepening pharma partnerships is driving durable growth.

  • AGM 2026

    The meeting covered board elections, auditor ratification, and executive compensation, with all proposals approved by shareholders. No questions were submitted during the Q&A session. Final voting results will be published in a Form 8-K filing.

  • Q1 saw strong revenue and EBITDA growth, led by Pharma Direct's 82% year-over-year increase and robust subscription momentum. Full-year guidance was raised, with Pharma Direct expected to grow over 50% and subscriptions scaling, despite ongoing pressure on prescription transactions revenue.

  • Shifts in insurance coverage and pharmacy closures are driving more consumers to seek cash savings and alternative prescription solutions. Growth is led by condition-based subscriptions and manufacturer partnerships, while a new Surescripts alliance aims to boost price transparency and adherence.

Fiscal Year 2025

Fiscal Year 2024

Fiscal Year 2023

Fiscal Year 2022

Fiscal Year 2021

Fiscal Year 2020